Discover
ELVN
Enliven Therapeutics, Inc.
48.76
2 x 35.90
2 x 62.23
bid
ask
-
1.99
3.92%
2 @ 04:00 PM
47.96 -0.80 (1.64%)
| Ytd | 216.62% | |
| 1y | 148.14% |
48.20
day range
51.84
14.79
52 week range
52.39
| Open | 51.20 | Prev Close | 50.75 | Low | 48.20 | High | 51.84 | Mkt Cap | 3.48B |
| Vol | 1.06M | Avg Vol | 1.38M | EPS | -1.64 | P/E | N/A | Forward P/E | -20.88 |
| Beta | 0.40 | Short Ratio | 3.89 | Inst. Own | 89.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-13 | 50-d Avg | 42.32 | 200-d Avg | 29.39 | 1yr Est | 62.89 |
| Income Statement | |||
| Operating Expenses | 27.82M | ||
| Research and Development Expense | 20.69M | ||
| Selling, General and Administrative Expense | 7.14M | ||
| Operating Income | -27.82M | ||
| Net Income | -23.63M | ||
| Net Income Common Stock | -23.63M | ||
| Net Income Common Stock (USD) | -23.63M | ||
| Consolidated Income | -23.63M | ||
| Earnings per Basic Share | -0.38 | ||
| Earnings per Basic Share (USD) | -0.38 | ||
| Earnings per Diluted Share | -0.38 | ||
| Earning Before Interest & Taxes (EBIT) | -23.63M | ||
| Earning Before Interest & Taxes (USD) | -23.63M | ||
| Weighted Average Shares | 62.80M | ||
| Weighted Average Shares Diluted | 62.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 132.18M | ||
| Cash and Equivalents (USD) | 132.18M | ||
| Investments | 320.22M | ||
| Investments Current | 320.22M | ||
| Current Assets | 463.14M | ||
| Property, Plant & Equipment Net | 310.00K | ||
| Total Assets | 464.85M | ||
| Current Liabilities | 11.49M | ||
| Total Liabilities | 11.49M | ||
| Accumulated Retained Earnings (Deficit) | -370.79M | ||
| Accumulated Other Comprehensive Income | -382.00K | ||
| Shareholders Equity | 453.37M | ||
| Shareholders Equity (USD) | 453.37M | ||
| Assets Non-Current | 1.72M | ||
| Trade and Non-Trade Payables | 1.64M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 107.00K | ||
| Net Cash Flow from Financing | 10.05M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 33.29M | ||
| Issuance (Purchase) of Equity Shares | 10.05M | ||
| Net Cash Flow from Investing | 42.53M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 42.53M | ||
| Net Cash Flow from Operations | -19.29M | ||
| Share Based Compensation | 7.40M | ||